Other
Otitis Media With Effusion
8
Pipeline Programs↗
1
Active Trials↗
3
Companies Involved↗
Otitis Media With Effusion is an early-stage landscape with 8 programs across 3 companies. The most active players are Novartis, Saffron Pharma, Takeda. 1 therapy is approved with 3 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical2
Phase 2
No programs
Phase 33
Analysis
Trial Status
6
clinical trials
Completed3 · 50%
Unknown status2 · 33%
Not yet recruiting1 · 17%
Clinical Trials
Trial Activity
6 trials
Intranasal Corticosteroid Spray for Preventing Otitis Media With Effusion After Radiotherapy in Nasopharyngeal Carcinoma
Not yet recruiting·UUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology·Phase 3·NCT07189572·168 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)